Patents Assigned to Cell4Cure AB
  • Patent number: 12582706
    Abstract: There is provided inter alia according to the invention an ex vivo method of obtaining tolerogenic antigen presenting cells (APCs) that have the capability to induce tolerance in the immune system to an antigen, the method comprising (a) isolating monocytes from a sample obtained from a mammal; and (b) culturing the isolated monocytes in a cell culture to induce differentiation of the monocytes into antigen presenting cells having a tolerogenic phenotype, wherein the cell culture comprises (i) retinoic acid and TGFbeta, (ii) retinoic acid, TGFbeta and an AhR agonist or (iii) retinoic acid and an AhR agonist.
    Type: Grant
    Filed: December 11, 2020
    Date of Patent: March 24, 2026
    Assignee: Cell4Cure AB
    Inventors: Lieneke Pool, Pavlos Englezou, Maria Wigren, Hanne Romedahl